tanshinone has been researched along with Bile Duct Obstruction in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jin, J; Li, Y; Qiu, F; Ren, J; Song, G; Tan, B; Wang, Q; Weng, F; Yan, D; Zou, B | 1 |
| Gao, Y; Hu, D; Liang, Q; Liu, C; Ma, Z; Tan, H; Tang, X; Wang, Y; Xiao, C; Zhang, B; Zhang, X | 1 |
2 other study(ies) available for tanshinone and Bile Duct Obstruction
| Article | Year |
|---|---|
15,16-dihydrotanshinone I in Danshen ethanol extract aggravated cholestasis by inhibiting Cyp3a11 mediated bile acids hydroxylation.
Topics: Animals; Bile Acids and Salts; Cholestasis; Cytochrome P-450 CYP3A; Ethanol; Hydroxylation; Lithocholic Acid; Membrane Proteins; Mice; Salvia miltiorrhiza | 2023 |
Tanshinone IIA exerts protective effects in a LCA-induced cholestatic liver model associated with participation of pregnane X receptor.
Topics: Abietanes; Animals; Cholestasis; Cytochrome P-450 CYP3A; Hep G2 Cells; Humans; Lithocholic Acid; Male; Mice, Inbred BALB C; Phytotherapy; Pregnane X Receptor; Protective Agents; Receptors, Steroid; RNA, Messenger | 2015 |